You are here

Plexxikon

Daiichi Sankyo unit claims $182m in Novartis patent dispute

Pharmaphorum

Wed, 12/6/23 - 10:31 am

Cancer drugmaker Plexxikon gets new life as Opna Bio

BioPharma Dive

Tue, 11/22/22 - 10:38 am

Daiichi Sankyo shuts down Plexxikon subsidiary to streamline Enhertu, ADC development

Endpoints

Wed, 01/12/22 - 11:26 pm

Novartis to pay nearly $178M in lawsuit over BRAF drug — and will be on the hook for royalty

Endpoints

Fri, 07/23/21 - 10:57 am

Biotech Novellus snaps up BRAF cancer drug from Daiichi's biotech unit Plexxikon

Fierce Biotech

Wed, 06/3/20 - 11:33 pm

Roche's vemurafenib plays a starring role at ASCO

Fierce Biotech

Mon, 06/6/11 - 09:36 am

Roche cancer programs angle for a starring role at ASCO

Fierce Biotech

Wed, 05/18/11 - 11:46 am

10 promising late-stage cancer drugs

Fierce Biotech

Tue, 04/5/11 - 10:47 pm

Daiichi Sankyo, Kyowa Hakko Signal More Japanese Drug Takeovers

Bloomberg

Wed, 03/2/11 - 10:33 am

Kyowa Hakko Kirin

Daiichi Sankyo nabs tiny Plexxikon in $935M deal

Fierce Biotech

Tue, 03/1/11 - 07:57 am

Roche Scores Big With Plexxikon and Immunogen Deals

Seeking Alpha

Tue, 01/25/11 - 09:30 am

personalized medicine

Four Big Areas to Watch at the Upcoming ASCO Meeting, Biotech's Biggest Cancer Confab

BNET Pharma

Mon, 05/24/10 - 08:03 am

personalized medicine

Plexxikon Treats Initial Patient with First-in-Class Drug in Phase 1 Trial

Pipeline Review

Sat, 10/10/09 - 12:06 pm

rheumatoid arthritis